Federal contractor · public award history
OREXO US INC
Parent: OREXO AB G3NJFQBBMP39
- Awards we know about
- 2
- Typical size
- $8.45M
- Middle of their public awards
- Dollars on those awards
- $8.45M
Most of their awards we can see fall roughly between $8.45M and $8.45M.
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Apr 23, 2027
- Activation date
- May 4, 2026
- Primary NAICS (SAM)
- 325412
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Health and Human Services (1)
- Department of Veterans Affairs (1)
Industries & product codes
Award history
- Department of Health and Human Services$8.45M
CLINICAL DEVELOPMENT OF OX390 (ATIPAMEZOLE) AS AN ?2 AGONIST REVERSAL AGENT FOR HUMAN USE TO COUNTERACT THE SEDATIVE EFFECTS OF XYLAZINE, MEDETOMIDINE, AND OTHER ?2 AGONISTS
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCT FSS CONTRACT AWARD
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.